Phase I trial of MMI-0100 in volunteers in the Netherlands
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2015
At a glance
- Drugs MMI 0100 (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions; First in man
- Sponsors Moerae Matrix
- 28 Jul 2015 Results published in a Moerae Matrix media release.
- 28 Jul 2015 Status changed from recruiting to completed according to a Moerae Matrix media release.
- 23 Sep 2014 New trial record